Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2018; (6): CD001190.
Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN), Deutsche Gesellschaft für Neurologie (DGN). S3-Leitlinie Demenzen. AWMF-Registernr.: 038 - 013. 2016.
Fink HA, Hemmy LS, Linskens EJ et al. Diagnosis and Treatment of Clinical Alzheimer's-Type Dementia: A Systematic Review. (AHRQ Comparative Effectiveness Reviews; No. 223). 2020.
Fink HA, Linskens EJ, MacDonald R et al. Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia. Ann Intern Med 2020; 172(10): 656-668.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Cholinesterase inhibitors in Alzheimer's disease: Final report; commission A05-19A. 2007.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Ginkgo compounds in Alzheimer's disease: Final report; commission A05-19B. 2008.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Memantine in Alzheimer's disease: Final report; commission A05-19C. 2009.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Responder analyses for memantine in Alzheimer´s disease: Rapid Report; commission A10-06. 2011.
Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis. PLoS One 2015; 10(4): e0123289.
McShane R, Westby MJ, Roberts E et al. Memantine for dementia. Cochrane Database Syst Rev 2019; (3): CD003154.
Ströhle A, Schmidt DK, Schultz F et al. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials. Am J Geriatr Psychiatry 2015; 23(12): 1234-1249.
Yuan Q, Wang CW, Shi J et al. Effects of Ginkgo biloba on dementia: An overview of systematic reviews. J Ethnopharmacol 2017; 195: 1-9.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.